No Data
No Data
Express News | Avalo Therapeutics Shares Are Trading Higher After BVF Partners Disclosed in a 13G Filing That It Reported a 9.99% Stake in the Company
Express News | Avalo Therapeutics 13G Filing Shows BVF Partners L.P. Reported a 9.99% Stake In The Co As Of August 13, 2024
Express News | Ra Capital Management LP Reports 9.99% Passive Stake in Avalo Therapeutics Inc as of August 13 - SEC Filing
Oppenheimer Sticks to Their Buy Rating for Avalo Therapeutics (AVTX)
Avalo Therapeutics Shareholders Back Board and Strategies
Express News | Avalo Therapeutics Q2 2024 GAAP EPS $(14.07) May Not Be Comparable To $(6.70) Estimate; Cash On Hand Of Approximately $93.4M As Of June 30, 2024 With Expected Cash Runway Into 2027
No Data